CS logo
small CS logo
Edward Hospital/Cancer Center

Naperville, Illinois, United States
Cancer treatment center in Naperville, Illinois
120 Spalding Dr #111, Naperville, IL 60540

About Edward Hospital/Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
35
SWOG Cancer Research Network
24
NSABP Foundation Inc
12
Alliance for Clinical Trials in Oncology
11
NRG Oncology
8
ECOG-ACRIN Cancer Research Group
5
Hoffmann-La Roche
4
ETOP IBCSG Partners Foundation
2
Northwestern University
2
Bristol-Myers Squibb
1
CTI BioPharma
1
Total Rows: 22

Clinical Trials at Edward Hospital/Cancer Center


During the past decade, Edward Hospital/Cancer Center conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 49 clinical trials were completed, i.e. on average, 125.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 16 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years665566228877552299131355446666Started TrialsCompleted Trails2015201620172018201920202021051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
1999-07-01
2011-01-01
Completed
1,023
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76

Rows per page:

1–100 of 116

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Edward Hospital/Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "NSABP Foundation Inc" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Edward Hospital/Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NSABP Foundation Inc" with 6 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 34 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 35National CancerInstitute (NCI): 35SWOG Cancer ResearchNetwork: 24SWOG Cancer ResearchNetwork: 24NSABP Foundation Inc: 12NSABP Foundation Inc: 12Alliance for ClinicalTrials in Oncology: 11Alliance for ClinicalTrials in Oncology: 11NRG Oncology: 8NRG Oncology: 8ECOG-ACRIN CancerResearch Group: 5ECOG-ACRIN CancerResearch Group: 5Hoffmann-La Roche: 4Hoffmann-La Roche: 4ETOP IBCSG PartnersFoundation: 2ETOP IBCSG PartnersFoundation: 2Northwestern University: 2Northwestern University: 2Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 59National CancerInstitute (NCI): 59NRG Oncology: 10NRG Oncology: 10SWOG Cancer ResearchNetwork: 8SWOG Cancer ResearchNetwork: 8Cancer and LeukemiaGroup B: 6Cancer and LeukemiaGroup B: 6NSABP Foundation Inc: 6NSABP Foundation Inc: 6Canadian Cancer Trials Group: 5Canadian Cancer Trials Group: 5NCIC Clinical Trials Group: 5NCIC Clinical Trials Group: 5North Central CancerTreatment Group: 5North Central CancerTreatment Group: 5Eastern CooperativeOncology Group: 4Eastern CooperativeOncology Group: 4Genentech, Inc.: 4Genentech, Inc.: 4

Clinical Trials Conditions at Edward Hospital/Cancer Center


According to Clinical.Site data, the most researched conditions in "Edward Hospital/Cancer Center" are "Breast Cancer" (22 trials), "Lung Cancer" (5 trials), "Lymphoma" (5 trials), "Recurrent Breast Carcinoma" (5 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (5 trials). Many other conditions were trialed in "Edward Hospital/Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Edward Hospital/Cancer Center


Most popular intervention types in "Edward Hospital/Cancer Center" are "Drug" (96 trials), "Other" (58 trials), "Biological" (34 trials), "Radiation" (32 trials) and "Procedure" (24 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (26 trials), "Laboratory Biomarker Analysis" (24 trials), "Placebo" (13 trials), "Radiation Therapy" (12 trials) and "Computed Tomography" (11 trials). Other intervention names were less common.

Clinical Trials Genders at Edward Hospital/Cancer Center


The vast majority of trials in "Edward Hospital/Cancer Center" are 83 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Edward Hospital/Cancer Center


Currently, there are NaN active trials in "Edward Hospital/Cancer Center". undefined are not yet recruiting, 20 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Edward Hospital/Cancer Center, undefined suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Edward Hospital/Cancer Center, 2 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 79Phase 3: 79Phase 2: 34Phase 2: 34Not Applicable: 6Not Applicable: 6Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 43Active, not recruiting: 43Completed: 38Completed: 38Recruiting: 20Recruiting: 20Terminated: 12Terminated: 12Unknown status: 2Unknown status: 2No longer available: 1No longer available: 1